LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
0288U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0288U.
Elevated code risk
Signal breakdown
7 shown · 7 total in platform
Risk: Elevated
0
Critical
0%
3
High
43%
4
Routine
57%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
LCD L38327: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer — Noridian
Policy LCD-L38327 · Oncology
New billing guidelines for lung cancer genomic testing.
LCD L38284: MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer — CGS
Policy LCD-L38284 · Oncology
New billing rules for lung cancer predictive classifiers effective 2025.
LCD L38238: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer — Palmetto GBA
Policy LCD-L38238 · Oncology
New billing guidelines for lung cancer tests effective July 2025.
LCD L38329: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer — Noridian
Policy LCD-L38329 · Oncology
New billing guidelines for lung cancer genetic testing effective in 2025.
Audit documentation
Building an audit file that includes 0288U?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription